Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization

References

• Abdallah, M., et al., 2013. Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. International journal of pharmaceutical sciences and research, 4, 1757–1765.
   Google Scholar
• Abdel Azim, A.M., et al., 2014. Transdermal films containing tizanidine: invitro and in vivo evaluation. Journal of drug delivery science and technology, 24 (1), 92–99.
   Web of Science ®Google Scholar
• Abd-Elbary, A., El-laithy, H.M., and Tadros, M.I., 2008. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. International journal of pharmaceutics, 357 (1–2), 189–198.
   PubMed Web of Science ®Google Scholar
• Abdelbary, G., 2011. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharmaceutical development and technology, 16 (1), 44–56.
   PubMed Web of Science ®Google Scholar
• Abdelbary, G., et al., 2011. Toluidine blue loaded transferosomesfor topical photodynamic therapy: formulation and characterization. International journal of research in pharmaceutical sciences, 2, 537–544.
   Google Scholar
• Abdelbary, A.A. and AbouGhaly, M.H., 2015. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. International journal of pharmaceutics, 485 (1–2), 235–243.
   PubMed Web of Science ®Google Scholar
• Abdelbary, G.A. and Aburahma, M.H., 2014. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. Journal of liposome research, 24, 1–15.
   PubMed Web of Science ®Google Scholar
• Abdelbary, G. and El-Gendy, N., 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech, 9 (3), 740–747.
   PubMed Web of Science ®Google Scholar
• Aboelwafa, A.A., El-Setouhy, D.A., and Elmeshad, A.N., 2010. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS PharmSciTech, 11 (4), 1591–1602.
   PubMed Web of Science ®Google Scholar
• Aboud, H.M., et al., 2016. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation. Drug delivery, 23, 2471–2481.
   PubMed Web of Science ®Google Scholar
• Agarwal, R., Katare, O.P., and Vyas, S.P., 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. International journal of pharmaceutics, 228 (1–2), 43–52.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi, A.M., Abdelbary, A.A., and Aburahma, M.H., 2015. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. International journal of pharmaceutics, 485 (1–2), 329–340.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi, A.M., Khowessah, O.M., and Shoukri, R.A., 2014. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. International journal of pharmaceutics, 472 (1–2), 304–314.
   PubMed Web of Science ®Google Scholar
• Ambati, J., et al., 2000. Transscleral delivery of bioactive protein to the choroid and retina. Investigative ophthalmology & visual science, 41, 1186–1191.
   PubMed Web of Science ®Google Scholar
• Arzani, G., et al., 2015. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. International journal of nanomedicine, 10, 4797–4813.
   PubMed Web of Science ®Google Scholar
• Aziz, D.E., Abdelbary, A.A., and Elassasy, A.I., 2018. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Drug delivery, 25 (1), 815–826.
   PubMed Web of Science ®Google Scholar
• Basha, M., et al., 2013. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. Journal of liposome research, 23 (3), 203–210.
   PubMed Web of Science ®Google Scholar
• Bayindir, Z.S. and Yuksel, N., 2010. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of pharmaceutical sciences, 99 (4), 2049–2060.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Wang, M., and Fang, L., 2013. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems. Drug delivery, 20 (5), 199–209.
   PubMed Web of Science ®Google Scholar
• Conacher, M., Alexander, J., and Brewer, J.M., 2001. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine, 19 (20–22), 2965–2974.
   PubMed Web of Science ®Google Scholar
• El Zaafarany, G.M., et al., 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. International journal of pharmaceutics, 397 (1–2), 164–172.
   PubMed Web of Science ®Google Scholar
• El-Mahrouk, G.M., et al., 2014. Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance. International journal of pharmaceutics, 467 (1–2), 100–112.
   PubMed Web of Science ®Google Scholar
• Elsherif, N.I., Shamma, R.N., and Abdelbary, G., 2017. Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation. AAPS PharmSciTech, 18 (2), 551–562.
   PubMed Web of Science ®Google Scholar
• Fong Yen, W., et al., 2015. Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system. The scientific world journal, 2015, 1–7.
   Google Scholar
• Ghanbarzadeh, S. and Arami, S., 2013. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed research international, 2013, 1–7.
   Web of Science ®Google Scholar
• Gonzalez-Rodriguez, M.L., et al., 2016. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process. Drug development and industrial pharmacy, 42 (10), 1683–1694.
   PubMed Web of Science ®Google Scholar
• Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by a niosome system. International journal of pharmaceutics, 244 (1–2), 73–80.
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen, P.L. and Bouwstra, J.A., 2005. Vesicles as a tool for transdermal and dermal delivery. Drug discovery today: technologies, 2 (1), 67–74.
   PubMedGoogle Scholar
• ICH. 2005. ICH Q2 (R1) Validation of Analytical Procedures. Geneva: ICH Harmonised Tripartite Guideline.
   Google Scholar
• Khalil, R.M., et al., 2017. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. Journal of liposome research, 27 (4), 312–323.
   PubMed Web of Science ®Google Scholar
• Kumbhar, D., Wavikar, P., and Vavia, P., 2013. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS PharmSciTech, 14 (3), 1072–1082.
   PubMed Web of Science ®Google Scholar
• Kushla, G.P., et al., 1993. Noninvasive assessment of anesthetic activity of topical lidocaine formulations. Journal of pharmaceutical sciences, 82 (11), 1118–1122.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2012. Diclofenac/biodegradable polymer micelles for ocular applications. Nanoscale, 4 (15), 4667–4673.
   PubMed Web of Science ®Google Scholar
• Madni, A., et al., 2018. Enhancement of dissolution and skin permeability of pentazocine by proniosomes and niosomal gel. AAPS PharmSciTech, 19 (4), 1544–1553.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., Kongkaneramit, L., and Manosroi, J., 2004. Stability and transdermal absorption of topical amphotericin B liposome formulations. International journal of pharmaceutics, 270 (1-2), 279–286.
   PubMed Web of Science ®Google Scholar
• Marwah, H., et al., 2016. Permeation enhancer strategies in transdermal drug delivery. Drug delivery, 23 (2), 564–578.
   PubMed Web of Science ®Google Scholar
• Moawad, F.A., Ali, A.A., and Salem, H.F., 2017. Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance. Drug delivery, 24 (1), 252–260.
   PubMed Web of Science ®Google Scholar
• Mohawed, O.A.M., EL-Ashmoony, M.M., and EL-Gazayerly, O.N., 2014. Niosome-encapsulated clomipramine for transdermal controlled delivery. International journal of pharmacy and pharmaceutical sciences, 6, 567–575.
   Google Scholar
• Morrow, D.I.J., et al., 2007. Inovative strategies for enhancing topical and transdermal drug delivery. The open drug delivery journal, 1 (1), 36–59.
   Google Scholar
• Muller, R.H., Jacobs, C., and Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Advanced drug delivery reviews, 47 (1), 3–19.
   PubMed Web of Science ®Google Scholar
• Mutalik, S., et al., 2009. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug delivery, 16 (2), 82–91.
   PubMed Web of Science ®Google Scholar
• Muzzalupo, R., et al., 2011. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. European journal of pharmaceutics and biopharmaceutics: official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 79 (1), 28–35.
   PubMed Web of Science ®Google Scholar
• Nagarwal, R.C., et al., 2009. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. Journal of controlled release: official journal of the controlled release society, 136 (1), 2–13.
   PubMed Web of Science ®Google Scholar
• Panchagnula, R., 1997. Transdermal delivery of drugs. Indian journal of pharmacology, 29, 140–156.
   Google Scholar
• Pardakhty, A., Varshosaz, J., and Rouholamini, A., 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics, 328 (2), 130–141.
   PubMed Web of Science ®Google Scholar
• Patel, K.K., Kumar, P., and Thakkar, H.P., 2012. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech, 13 (4), 1502–1510.
   PubMed Web of Science ®Google Scholar
• Peppas, N.A. and Sahlin, J.J., 1989. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. International journal of pharmaceutics, 57 (2), 169–172.
   Web of Science ®Google Scholar
• Rajabalaya, R., et al., 2016. Tolterodine tartrate proniosomal gel transdermal delivery for overactive bladder. Pharmaceutics, 8 (3), 27–15.
   Web of Science ®Google Scholar
• Sankhyan, A. and Pawar, P.K., 2013. Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. DARU journal of pharmaceutical sciences, 21 (1), 7–8.
   Google Scholar
• Sinico, C., et al., 2005. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. Journal of controlled release: official journal of the controlled release society, 103 (1), 123–136.
   PubMed Web of Science ®Google Scholar
• Soliman, S.M., et al., 2016. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits. Drug delivery, 23 (5), 1608–1622.
   PubMed Web of Science ®Google Scholar
• Someshwar, K., et al., 2011. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride. Acta pharmaceutica, 61 (2), 217–226.
   PubMed Web of Science ®Google Scholar
• Teaima, M.H., et al., 2018. Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Drug development and industrial pharmacy, 44 (1), 158–171.
   PubMed Web of Science ®Google Scholar
• Uchegbu, F.I. and Vyas, S.P., 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International journal of pharmaceutics, 172 (1–2), 33–70.
   Web of Science ®Google Scholar
• Westfall, T.C. and Westfall, D.P., 2005. Adrenergic agonists and antagonists. In L. Brunton, B. Chabner, B. Knollman, eds. Goodman & Gilman's: The pharmacological basis of therapeutics. Access Pharmacy, McGraw-Hill Global Education Holdings, LLC, 237–295.
   Google Scholar
• Yusuf, M., Sharma, V., and Pathak, K., 2014. Nanovesicles for transdermal delivery of felodipine: development, characterization, and pharmacokinetics. International journal of pharmaceutical investigation, 4 (3), 119–130.
   PubMedGoogle Scholar